Boers M - Search Results

1

OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.

Tugwell P, Boers M. Tugwell P, et al. Among authors: boers m. J Rheumatol. 1993 Mar;20(3):528-30. J Rheumatol. 1993. PMID: 8478864 Review. No abstract available.

2

Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.

Boers M, Bensen WG, Ludwin D, Goldsmith CH, Tugwell P. Boers M, et al. J Rheumatol. 1992 Apr;19(4):534-7. J Rheumatol. 1992. PMID: 1593573 Clinical Trial.

3

Long acting drug combinations in rheumatoid arthritis: a formal overview.

Boers M, Ramsden M. Boers M, et al. J Rheumatol. 1991 Mar;18(3):316-24. J Rheumatol. 1991. PMID: 1856802 Review.

4

Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis.

Boers M, Dijkmans BA, van Rijthoven AW, Goei Thè HS, Cats A. Boers M, et al. J Rheumatol. 1990 Jan;17(1):38-42. J Rheumatol. 1990. PMID: 2179550 Clinical Trial.

5

Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial Conference.

Goldsmith CH, Duku E, Brooks PM, Boers M, Tugwell PS, Baker P. Goldsmith CH, et al. Among authors: boers m. J Rheumatol. 1995 Jul;22(7):1420-30. J Rheumatol. 1995. PMID: 7562790

6

Assessing the activity of rheumatoid arthritis.

Boers M, van Riel PL, Felson DT, Tugwell P. Boers M, et al. Baillieres Clin Rheumatol. 1995 May;9(2):305-17. doi: 10.1016/s0950-3579(05)80192-x. Baillieres Clin Rheumatol. 1995. PMID: 7656342 Review.

7

Health status instruments / utilities.

Bellamy N, Boers M, Felson D, Fries J, Furst D, Henry D, Liang M, Lovell D, March L, Strand V, et al. Bellamy N, et al. Among authors: boers m. J Rheumatol. 1995 Jun;22(6):1203-7. J Rheumatol. 1995. PMID: 7674258

8

Wrist splints in rheumatoid arthritis: a question of belief?

Spoorenberg A, Boers M, Van der Linden S. Spoorenberg A, et al. Among authors: boers m. Clin Rheumatol. 1994 Dec;13(4):559-63. doi: 10.1007/BF02242994. Clin Rheumatol. 1994. PMID: 7697955

9

Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?

Boers M, Felson DT. Boers M, et al. J Rheumatol. 1994 Sep;21(9):1773-4. J Rheumatol. 1994. PMID: 7799368 No abstract available.

10

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, Smolen JS, Khaltaev N, Muirden KD. Boers M, et al. J Rheumatol Suppl. 1994 Sep;41:86-9. J Rheumatol Suppl. 1994. PMID: 7799394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters